Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, 730000, China
NCT Number: NCT03937037
In this prospective study, the investigators assessed the utility of intermittent saline irrigation in reducing the recurrent rate of choledocholithiasis after the endoscopic extraction for common bile duct stones, and it does not increase the rate of procedure-related complications.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Lanzhou, Gansu, 730000, China
In recent years, an endoscopic retrograde cholangiopancreatography (ERCP) is the golden standard procedure to remove the common bile duct stones(CBD). Nevertheless, it is reported that the recurrence rate of CBD stones is 4% to 24% after ERCP. The contributing factors were periampullar diverticulum, situ gallbladder, and incomplete CBD stone clearance. The main reason of stone recurrence is incomplete CBD stone clearance including remnant stone fragments themselves and tinny fragments can act as a nidus for further CBD stone growth. It is difficult to retrieve these fine fragments completely using conventional devices such as retrieval basket and ballon. Therefore, the investigators attempt to remove residual stone fragments by means of saline infusion. Saline irrigation has many advantages such as better effect and less side effect and no extra cost. It is reported that use intraductal ultrasonography (IDUS) to demonstrate residual CBD stones. However, IDUS has limited availability in clinical practice. The single-operator cholangioscopy (SOC)-system gains widespread acceptance because of its independent washing channels and direct viewing.
The purpose of this study is to evaluate whether saline solution irrigation would decrease the recurrent rate of choledocholithiasis after endoscopy retrieval stones.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
100ml saline irrigation after CBD stone removal with routine ERCP procedure
Time frame: 3 years
Number of Participants with stones detected by Magnetic resonance cholangiopancreatography, CT or US confirms CBD stone recurrence no matter symptomatic choledocholithiasis or not
Time frame: 3 years
Temperature should be more than 38 ℃, with right upper abdominal pain, blood routine showing the total amount of the White Blood Cell (WBC), and the amount of polymorphonuclear neutrophil(PMN) are above normal
Time frame: 3 years
Typical abdominal pain, with the level of serum amylase increasing at least 3 times of the normal range within 24 hours after surgery, and there are also radiographic evidence suggesting the shape of pancreas has changed
Time frame: 1 month
Was defined as the clinical and endoscopic evidence of hemorrhage associated. with a decreasing the hemoglobin level >2 g/dl
Time frame: 1 month
Was defined as the presence of air or contrast in the retroperitoneal space
Time frame: 7 days
From the moment the endoscope entered, to the moment withdraw the scope
Hepatopancreatobiliary Surgery Institute of Gansu Province
Other
Effect of Intermittent Saline Irrigation in Reducing Choledocholithiasis Recurrence After ERCP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02967926
Bile Duct Diseases, Biliary Tract Diseases
View Trial DetailsNCT04456218
Biliary Tract, Biliary Tract Diseases
Tainan, Taiwan
View Trial DetailsNCT05962853
Biliary Tract Diseases, Calculi
Adana, Yüreğir / Adana, Turkey (Türkiye)
View Trial DetailsNCT06676241
Acute Pancreatitis (AP), Bile Duct Diseases
Moscow, Moscow Oblast, Russia
View Trial Details